Alabama Opens First Medical Cannabis Dispensary, Eleven More Licensed

First Dispensary Operational, Patient Access Begins

Alabama's medical cannabis program transitioned from regulatory framework to patient service with the opening of its first licensed dispensary in late May 2026. The facility began dispensing cannabis products to qualified patients holding valid medical marijuana cards issued by the Alabama Medical Cannabis Commission. The state authorized medical cannabis in 2021 under the Darren Wesley 'Wen' Kendrick Act, but licensing and regulatory buildout delayed patient access until this month.

The commission hasn't publicly disclosed the dispensary's location or operator name in its most recent updates. Industry observers expect the agency to release a full list of operational dispensaries once additional locations complete final inspections.

Eleven Additional Dispensaries Cleared for Launch

The Alabama Medical Cannabis Commission issued final operating licenses to eleven dispensaries beyond the inaugural location, bringing the state's total approved retail footprint to twelve facilities. These dispensaries completed background checks, facility inspections, and security protocol reviews required under the commission's Phase II licensing rules published in December 2025.

Commission regulations cap the total number of dispensary licenses statewide, though the precise limit hasn't been codified in publicly available rulemaking documents. The current cohort of twelve represents the first wave of approvals under the state's merit-based application system, which scored applicants on financial stability, operational plans, and community integration.

Qualifying Conditions and Patient Enrollment

Alabama's medical cannabis program covers fifteen qualifying conditions, including cancer, chronic pain, PTSD, epilepsy, and terminal illnesses. Patients must obtain a recommendation from a physician registered with the commission's practitioner database. As of May 15, 2026, the commission reported issuing approximately 8,200 patient cards, according to data posted on its public dashboard.

Home cultivation isn't permitted. Patients may purchase up to seventy grams of cannabis flower per ninety-day period, or equivalent amounts in concentrate, edible, or topical form. Smoking is prohibited. Only vaporization, sublingual, topical, and oral administration routes are allowed under the Kendrick Act.

Supply Chain: Cultivation and Processing Licenses

The commission licensed five integrated cultivator-processors to supply the state's dispensaries, each operating under strict seed-to-sale tracking requirements. These vertically integrated licensees handle both cultivation and manufacturing, producing flower, vape cartridges, tinctures, and capsules. The commission's January 2026 guidance mandated testing for potency, pesticides, heavy metals, and microbial contaminants at independent laboratories before any product reaches dispensary shelves.

Alabama doesn't allow out-of-state cannabis transfers. All products sold in-state must be grown, processed, and tested within Alabama's borders. This closed-loop model mirrors regulatory structures in Florida and Ohio, where multi-state operators can't import inventory from neighboring programs.

Timeline: Four Years from Bill to First Sale

The Darren Wesley 'Wen' Kendrick Act became law on May 17, 2021, but the first legal medical cannabis transaction didn't occur until May 2026—a forty-eight-month gap driven by rulemaking delays and litigation. The commission was established in September 2021. It published draft regulations in mid-2023 and accepted license applications in early 2024. Legal challenges from municipalities seeking to block dispensaries in their jurisdictions delayed final approvals by six months.

Provisional licenses arrived in October 2025. Final inspections and security audits extended into spring 2026, pushing the program's operational launch into late May.

What Comes Next for Alabama's Program

The commission is expected to announce a second licensing round in 2027, potentially adding dispensaries in underserved rural counties and expanding the cultivator pool. Current regulations allow the commission to issue additional licenses if patient demand exceeds supply or if geographic coverage gaps persist. Based on enrollment trends in demographically similar medical-only states, the state's patient count is projected to reach 15,000 by year-end 2026.

For operators and patients tracking the program's evolution, see the CannIntel topic hub on Alabama's medical cannabis program for regulatory updates and licensing data.

The next milestone: whether the commission releases dispensary-level sales data, which would clarify product mix, pricing, and patient purchasing patterns. That transparency would give Alabama's nascent market a data foundation comparable to established programs in Arkansas and Louisiana.